Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sheel BiotechNSE:SHEEL 18 ROA % is 9.08% as of Mar. 2026, which is at its 10-year median of 9.08. GuruFocus rates NSE:SHEEL with a GF Score™ of 18/100. The stock has 2 warning signs investors should review. Among 1,993 Consumer Packaged Goods companies, Sheel Biotech ranks better than 81.03% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Sheel Biotech's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹118 Mil.
Sheel Biotech's average Total Assets over the quarter that ended in Mar. 2026 was ₹1,295 Mil. Therefore, Sheel Biotech's annualized ROA % for the quarter that ended in Mar. 2026 was 9.08%.
The historical rank and industry rank for Sheel Biotech's ROA % or its related term are showing as below:
NSE:SHEEL'
s ROA % Range Over the Past 10 Years
Min: 4.85 Med: 9.08 Max: 10.48
Current: 9.08
During the past 5 years, Sheel Biotech's highest ROA % was 10.48%. The lowest was 4.85%. And the median was 9.08%.
NSE:SHEEL's ROA % is ranked better than 81.03% of 1993
companies
in the Consumer Packaged Goods industry
Industry Median: 3.31
vs NSE:SHEEL: 9.08
Sheel Biotech (NSE:SHEEL) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is one times the annual (Mar. 2026) net income data. The Revenue data used here is one times the annual (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Sheel Biotech ROA % Related Terms
Sheel Biotech ROA % Historical Data
* Premium members only.
The historical data trend for Sheel Biotech's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sheel Biotech ROA % Chart
Sheel Biotech Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Mar26
ROA %
4.85
5.43
10.48
9.81
9.08
Sheel Biotech Semi-Annual Data
Mar22
Mar23
Mar24
Mar25
Mar26
ROA %
4.85
5.43
10.48
9.81
9.08
NSE:SHEEL vs ADM, BG, TSN: ROA % Comparison
For the Farm Products subindustry, Sheel Biotech's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sheel Biotech ROA % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Sheel Biotech's ROA % distribution charts can be found below:
* The bar in red indicates where Sheel Biotech's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is one times the annual (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Sheel Biotech (NSE:SHEEL) has a ROA % of 9.08% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Sheel Biotech and its competitors. This is near median its historical median of 9.08. Over the past decade, Sheel Biotech's ROA % has ranged from 4.85 to 10.48. According to the industry distribution chart, Sheel Biotech ranks #378 out of 1993 companies in the Consumer Packaged Goods industry, placing it in the top 19%.
Is Sheel Biotech's ROA % too high?
Sheel Biotech's current ROA % of 9.08% is near median its 10-year median of 9.08. Over the past 10 years, this metric has ranged from a low of 4.85 to a high of 10.48. The Consumer Packaged Goods industry median ROA % is 3.31. Sheel Biotech's value of 9.08% is 174.3% above this industry median. Based on the distribution chart, Sheel Biotech ranks #378 out of 1993 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Sheel Biotech has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sheel Biotech's ROA % compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Sheel Biotech ranks #378 out of 1993 companies for ROA %. This places Sheel Biotech in the top 19% of its industry — outperforming the majority of peers. The industry median ROA % is 3.31. Sheel Biotech's value of 9.08% is 174.3% above this benchmark. Historically, Sheel Biotech's own ROA % has ranged from 4.85 to 10.48 over the past decade. While the company's 10-year median is 9.08 vs. the industry median of 3.31, Sheel Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Consumer Packaged Goods company?
The median ROA % among Consumer Packaged Goods companies is 3.31, based on 1,993 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sheel Biotech's current ROA % of 9.08% is 174.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Sheel Biotech and its competitors. For the Consumer Packaged Goods industry, the median ROA % is 3.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sheel Biotech's current ROA % is 9.08%, which is near median its own 10-year median of 9.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sheel Biotech stock overvalued right now?
Sheel Biotech (NSE:SHEEL) has a current ROA % of 9.08%. The current ROA % is 9.08%, which is near median its 10-year median of 9.08 and 174.3% above the Consumer Packaged Goods industry median of 3.31. Sheel Biotech's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Sheel Biotech (NSE:SHEEL), the current ROA % is 9.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
18GF Score
Get the complete analysis for NSE:SHEEL
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SHEEL has been successfully added to your 
